Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
The University of Texas Health Science Center, Houston
The University of Texas Health Science Center, Houston
University of Texas Southwestern Medical Center
OHSU Knight Cancer Institute
NYU Langone Health
City of Hope Medical Center
Northwestern University